Trial Profile
Effectiveness of Paritaprevir/Ombitasvir/Ritonavir +/- Dasabuvir in a cohort of real life HCV infection in Mono- and Co-infected Patients with HIV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2017
Price :
$35
*
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Dec 2017 New trial record
- 27 Oct 2017 Results presented at the 16th European AIDS Conference